Výsledky vyhledávání - "Lin, Xuanjia"

Akademický článek

Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy

Autor: Bu, Xiaoyun, Liu, Shuang, Wen, Dongsheng, Kan, Anna, Xu, Yujie, Lin, Xuanjia, Shi, Ming

Publikováno v: In Molecular Therapy - Oncolytics 15 September 2022 26:226-244

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Additional file 5 of One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

Autor: Lai, Zhicheng, Huang, Yexing, Wen, Dongsheng, Lin, Xuanjia, Kan, Anna, Li, Qijiong, Wei, Wei, Chen, Minshan, Xu, Li, He, Minke, Shi, Ming

Additional file 5: Figure S3. Forest plot of factors associated with OS (A) and PFS (B) in PSM cohort treated with HAIC 1d versus HAIC 2d. PSM, propensity score matching.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331641ff6d13e0ee49977259f68d5270

Zobrazit plný text záznamu

Additional file 1 of A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma

Autor: Bu, Xiaoyun, Ma, Luyao, Liu, Shuang, Wen, Dongsheng, Kan, Anna, Xu, Yujie, Lin, Xuanjia, Shi, Ming

Additional file 1: Table S1. Description of the datasets analyzed in this study. Table S2. Sequences of primers and short hairpin RNAs. Fig. S1. Restoration of TDRKH-AS1 in Huh7 cells after TDRKH-AS1 knockdown. TDRKH-AS1 was successfully restored aft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530da615640c981aa6dfc63486817a13

Zobrazit plný text záznamu

Additional file 2 of One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

Autor: Lai, Zhicheng, Huang, Yexing, Wen, Dongsheng, Lin, Xuanjia, Kan, Anna, Li, Qijiong, Wei, Wei, Chen, Minshan, Xu, Li, He, Minke, Shi, Ming

Additional file 2: Table S1. Treatment administration. Table S2. Univariate and multivariate analysis of overall survival and progression-free survival. Table S3. Univariate and multivariate analysis of overall survival and progression-free survival

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18d51d73e8d4783e7003c00c365cbd2a

Zobrazit plný text záznamu

Additional file 1 of One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

Autor: Lai, Zhicheng, Huang, Yexing, Wen, Dongsheng, Lin, Xuanjia, Kan, Anna, Li, Qijiong, Wei, Wei, Chen, Minshan, Xu, Li, He, Minke, Shi, Ming

Additional file 1. Methods. The details of ELISA.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1d1838a22a773123915d7f8ca8f5a0

Zobrazit plný text záznamu

Additional file 4 of One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

Autor: Lai, Zhicheng, Huang, Yexing, Wen, Dongsheng, Lin, Xuanjia, Kan, Anna, Li, Qijiong, Wei, Wei, Chen, Minshan, Xu, Li, He, Minke, Shi, Ming

Additional file 4: Figure S2. Kaplan-Meier curves of overall survival in BCLC stage C patients receiving HAIC alone (A), HAIC + TKIs (B) and HAIC + TKIs + ICIs (C) in PSM cohort. Kaplan-Meier curves of progression-free survival in BCLC stage C patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9011faa749c81431324472a5a76318d3

Zobrazit plný text záznamu

Additional file 3 of One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma

Autor: Lai, Zhicheng, Huang, Yexing, Wen, Dongsheng, Lin, Xuanjia, Kan, Anna, Li, Qijiong, Wei, Wei, Chen, Minshan, Xu, Li, He, Minke, Shi, Ming

Additional file 3: Figure S1. Kaplan-Meier curves of overall survival in BCLC stage C patients receiving HAIC alone (A), HAIC + TKIs (B) and HAIC + TKIs + ICIs (C). Kaplan-Meier curves of progression-free survival in BCLC stage C patients receiving H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c35183789b9296e49f407bc3821d1c

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání